March 11, 2025 - 06:13

In a recent discussion, Dr. Arti Masturzo, chief medical officer, highlighted the crucial role of education and technology in managing type 1 diabetes. The focus is on how patients can effectively utilize glucose monitors and insulin pumps, which are essential tools in their daily management of the condition.
Dr. Masturzo emphasized that clear guidance and troubleshooting support are vital for patients, as even minor errors in diabetes management can lead to serious health implications. The organization is committed to ensuring that patients are not only informed but also comfortable with the technology they rely on.
By fostering an environment of transparency and support, patients can gain confidence in their ability to manage their diabetes. This proactive approach aims to enhance the overall quality of life for those living with type 1 diabetes, empowering them to take charge of their health with the right tools and knowledge at their disposal.
April 22, 2026 - 22:45
Thinking About Selling Your Office Technology Business?Considering an exit from your office technology dealership? The path to a successful sale may hold surprising parallels with an entirely different industry: the food business. Key cross-over...
April 22, 2026 - 01:41
Summer electronics camps help high school students explore technology careersParents of high school students are encouraged to explore an exciting summer learning opportunity as two High School Electronics Camps will be offered in June 2026. These sessions are designed to...
April 21, 2026 - 01:39
Academy for Technology & The Classics junior is Santa Fe's youth poet laureateWillow Koseoglu, a junior at the Academy for Technology & The Classics, has been named Santa Fe`s latest youth poet laureate. This prestigious title recognizes her exceptional talent with words and...
April 20, 2026 - 00:06
Lobbying Update: $1,620,000 of DELL TECHNOLOGIES INC lobbying was just disclosedA new federal disclosure reveals that Dell Technologies Inc. spent $1,620,000 on lobbying activities during the first quarter of 2026. The filing, submitted under the Lobbying Disclosure Act,...